iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-202.41M -130.81M -134.41M -121.25M -108.14M -135.31M -112.64M -61.64M -28.41M 11.52M 96.65M 261.07M 329.72M 297.64M 214.52M 14.74M -65.58M -46.32M
Depreciation & Amortization
1.29M 1.26M 1.24M 1.14M 1.06M 979K 898K 894K 875K 845K 803K 731K 702K 657K 603K 595K 561K 540K
Stock-Based Compensation
27.13M 29.31M 29.94M 30.06M 29.57M 28.48M 27.02M 25.71M 24.38M 23.18M 21.56M 19.72M 17.94M 15.4M 13.79M 11.79M 9.57M 6.69M
Other Working Capital
7.19M -33.76M 20.06M 15.9M 5.53M 6.4M -13.59M -66.89M -98.26M -141.66M -231.25M -430.28M 143.03M 184.83M 281.93M 536.83M -2.17M -2.06M
Other Non-Cash Items
-39.68M -39.84M -43.35M -38.94M -10.38M -10.12M -10.23M -9.77M -7.11M -4.57M -1.72M 9K 8K 8K 12K -14K -13K -17K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
105.6M 40.53M 48.4M 11.55M -26.11M 6.37M -8.8M -72.36M -102.71M -144.72M -228.49M -424.36M 143.49M 190.22M 284.21M 539.37M 6.72M -1.38M
Operating Cash Flow
-108.06M -99.55M -98.18M -117.44M -113.98M -109.6M -103.76M -117.16M -112.97M -113.75M -111.19M -142.84M 491.86M 503.93M 513.14M 566.49M -48.74M -40.49M
Capital Expenditures
-630K -789K -1.63M -2.88M -3.53M -3.79M -2.97M -1.69M -1.02M -830K -938K -983K -1.43M -1.32M -1.18M -1.15M -726K -417K
Cash Acquisitions
n/a n/a n/a n/a n/a -20.8M -20.8M -20.8M -20.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-365.72M -425.29M -520.8M -537.63M -396.58M -393.82M -290.54M -193.96M -139.48M -53.02M -445K n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
423.17M 412.27M 391.31M 457.31M 431.18M 432.46M 366.26M 206.26M 128.26M 21M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-51K -49K -25K n/a -83K 20.72M 20.72M -423.84M -423.78M -444.58M -444.68M -120K -100K -154K -61K -62K -62K -14K
Investing Cash Flow
56.77M -13.86M -131.15M -83.21M 30.97M 34.75M 72.66M -434.02M -456.82M -477.43M -446.06M -1.1M -1.53M -1.47M -1.24M -1.22M -788K -431K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -1K -1K -1K -1K n/a n/a n/a 332K 332K 332K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.29M -200K -200K -211K n/a 218K 796K 2.17M 2.17M 2.23M 1.99M 2.97M 3.41M 3.33M 3.66M 2.14M 214.57M 213.27M
Financial Cash Flow
4.37M 122.25M 122.24M 122.26M 122.72M 557K 1.11M 2.18M 2.17M 2.23M 1.98M 2.97M 3.41M 3.33M 3.66M 2.14M 214.57M 213.27M
Net Cash Flow
-42.96M 10.2M -108.75M -80.07M 34.89M -78.67M -33.59M -548.07M -575.67M -598.68M -563.8M -147.44M 489.08M 502.76M 512.38M 559.8M 166.08M 173.67M
Free Cash Flow
-108.69M -100.33M -99.81M -120.32M -117.52M -113.39M -106.72M -118.85M -113.99M -114.58M -112.13M -143.82M 490.43M 502.61M 511.96M 565.34M -49.47M -40.9M